Literature DB >> 11581608

Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts.

I Mayers1, T Hurst, L Puttagunta, A Radomski, T Mycyk, G Sawicki, D Johnson, M W Radomski.   

Abstract

OBJECTIVES: Heart function is variably impaired after cardiopulmonary bypass. We hypothesized that, similar to other myocardial injury states, cardiopulmonary bypass leads to enhanced activity of nitric oxide synthase and matrix metalloproteinases.
METHODS: We obtained right atrial biopsy specimens and plasma samples at the onset and termination of cardiopulmonary bypass in 10 patients. Biopsy specimens were analyzed for nitric oxide synthase activity by using a citrulline assay, whereas plasma and tissue were analyzed for matrix metalloproteinase-9 and matrix metalloproteinase-2 activity by using zymography. Tissue inhibitor of metalloproteinase-4 was analyzed by means of Western blotting. The cellular expression of inducible nitric oxide, endothelial nitric oxide synthase, matrix metalloproteinase-2, and matrix metalloproteinase-9 was determined in right atrial biopsy samples from 3 additional patients by using the appropriate conjugated antibodies.
RESULTS: Nitric oxide synthase activity increased from the beginning to the end of bypass (4.46 +/- 1.07 vs 16.77 +/- 4.86 pmol citrulline/mg of protein per minute, respectively; P =.018). Pro-matrix metalloproteinase-9 activity increased in hearts (199 +/- 41 vs 660 +/- 177 density units/mg protein; P =.008) and plasma (14.1 +/- 4.6 vs 52.2 +/- 5.9 density units/mg protein; P =.008). Pro-matrix metalloproteinase-2 activity increased in the heart (201 +/- 23 vs 310 +/- 35 density units/mg protein, P <.05) but not in plasma. Tissue inhibitor of metalloproteinase-4 expression in the heart decreased (1574 +/- 280 vs 864 +/- 153 density units, P =.014).
CONCLUSIONS: Cardiopulmonary bypass activates enzymes mediating acute inflammation and organ injury (ie, nitric oxide synthase, matrix metalloproteinase-9, and matrix metalloproteinase-2). Decreased tissue inhibitor of metalloproteinase-4 expression allows relatively unopposed increases in matrix metalloproteinase tissue activity. We postulate that these changes play a role in the pathogenesis of heart dysfunction after bypass surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581608     DOI: 10.1067/mtc.2001.116207

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

1.  Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets.

Authors:  Anna Radomski; Paul Jurasz; Esmond J Sanders; Christopher M Overall; Heather F Bigg; Dylan R Edwards; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 2.  Peroxynitrite in myocardial ischemia-reperfusion injury.

Authors:  Manoj M Lalu; Wenjie Wang; Richard Schulz
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

3.  Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases.

Authors:  Ada W Y Chung; Anna Radomski; David Alonso-Escolano; Paul Jurasz; Michael W Stewart; Tadeusz Malinski; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2004-11-08       Impact factor: 8.739

4.  Dynamic changes in matrix metalloprotienase activity within the human myocardial interstitium during myocardial arrest and reperfusion.

Authors:  Francis G Spinale; Christine N Koval; Anne M Deschamps; Robert E Stroud; John S Ikonomidis
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

5.  Differential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypass.

Authors:  Bruce H Dorman; Robert E Stroud; Michael M Wyckoff; James L Zellner; Don Botta; Amy H Leonardi; John S Ikonomidis; Francis G Spinale
Journal:  J Cardiovasc Pharmacol       Date:  2008-04       Impact factor: 3.105

6.  Effects of aprotinin or tranexamic acid on proteolytic/cytokine profiles in infants after cardiac surgery.

Authors:  Tain-Yen Hsia; Tim C McQuinn; Rupak Mukherjee; Rachael L Deardorff; Jerry E Squires; Robert E Stroud; Fred A Crawford; Scott M Bradley; Scott T Reeves; Francis G Spinale
Journal:  Ann Thorac Surg       Date:  2010-06       Impact factor: 4.330

7.  Circulating matrix metalloproteinase-9 is transiently elevated after colorectal surgery.

Authors:  I H J T de Hingh; E T Waas; R M L M Lomme; T Wobbes; T Hendriks
Journal:  Int J Colorectal Dis       Date:  2004-02-17       Impact factor: 2.571

8.  Plasma matrix metalloproteinases in neonates having surgery for congenital heart disease.

Authors:  Ari R Joffe; Christina Schulz; Rhonda J Rosychuk; John Dyck; Ivan M Rebeyka; David B Ross; Richard Schulz; Po-Yin Cheung
Journal:  Heart Int       Date:  2009-06-30

9.  The Association of Matrix Metalloproteinases With Acute Kidney Injury Following CPB-Supported Cardiac Surgery.

Authors:  Erick D McNair; Jennifer Bezaire; Michael Moser; Prosanta Mondal; Josie Conacher; Aleksandra Franczak; Greg Sawicki; David Reid; Abass Khani-Hanjani
Journal:  Can J Kidney Health Dis       Date:  2021-07-16

10.  The Oak-wood Extract Robuvit® Improves Recovery and Oxidative Stress after Hysterectomy: A Randomized, Double-blind, Placebo-controlled Pilot Study.

Authors:  Vladimír Ferianec; Matej Fülöp; Miriam Ježovičová; Jana Radošinská; Marta Husseinová; Michaela Feriancová; Dominika Radošinská; Miroslav Barančík; Jana Muchová; Petra Hȍgger; Zdeňka Ďuračková
Journal:  Nutrients       Date:  2020-03-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.